All
Breaking Down the Benefits of Clinical Trial Participation in Cancer Care
Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of participating in a clinical trial.
Smoking Data May Guide Improved Lung Cancer Care and Patient Support
Most patients in accredited hospitals had smoking discussions documented, showing key care opportunities and smoking’s impact on treatment outcomes.
Renewal and Healing from Testicular Cancer This May
After testicular cancer, I’ve learned to guard my mood, seek small joys and embrace healing and renewal with every sunrise this spring.
First Patient Dosed With Azenosertib in Cyclin E1+ Ovarian Cancer
The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.
Pretreatment Baseline Screening for Breast Cancer-Related Lymphedema
New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.
Dosing of PAS-004 Begins in Patients in MAPK-Driven Tumors
Enrollment and initial dosing of PAS-004 at 30 milligrams has begun in three patients with MAPK pathway-driven advanced solid tumors.
Recapping Every FDA Approval Announced in April for Cancer Care
Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types.
Managing Fatigue During Breast Cancer Treatment: Tips for Conserving Energy
Breast cancer treatment is a physical, emotional, and mental challenge. Facing cancer and its side effects demands extraordinary physical, emotional, and spiritual stamina.
Breaking Down the Stigma and How to Better Understand Rare Blood Cancers
Dr. Neha Mehta-Shah discusses ways patients with rare blood cancers, such as lymphoma, can better understand their specific subtype of disease.
Triage Health Conference: Free Education to Navigate Health Care
Triage Health offers free, expert-led education on the legal and practical issues that impact individuals coping with chronic or serious medical conditions.
Advances in surgical techniques and targeted therapies for Pancreatic Cancer
Pancreatic cancer is one of the most challenging cancers to treat.
Endoscopic Procedure Removes GIST Without Surgery
A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery and fewer complications.
Teddy Bears Are a Good Therapy for Adults With Cancer
Teddy bears offer emotional comfort and connection for adults with cancer, easing anxiety and fostering trust during treatment.
In Vivo CD19 CAR-T Leads to Remission in DLBCL Without Lymphodepletion
A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following novel in vivo CD19 CAR-T therapy.
First Patient Dosed in Trial of Ziftomenib for Advanced GIST
A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following progression on Gleevec.
BRAF Inhibitor Gel Improves Acne-Like Skin Rashes in Colorectal Cancer
LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers.
The Impact of Breast Cancer on Self-Image
A breast cancer diagnosis brings about many losses.
FDA Completes Review of Hepzato Combo in HER2– Metastatic Breast Cancer
The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer.
Patient and Disease-Related Factors Influence Outcomes in Urothelial Cancer
Patient and disease-related factors influence surgical recovery and treatment outcomes after Keytruda and Padcev in advanced urothelial cancer.
Aidixi Plus Bacillus Calmette-Guérin Effective in Bladder Cancer
Aidixi plus BCG showed strong early efficacy and manageable safety in patients with high-risk, HER2-expressing non–muscle-invasive bladder cancer.
Lingering Stress After Follicular Lymphoma Remission is a Challenge
Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue to weigh heavily on me.
CM24 Combo With Biomarker Targeting Improves Survival in Pancreatic Cancer
CM24 plus Opdivo and chemo improved survival in pancreatic cancer with CEACAM1 biomarkers, supporting a biomarker-driven phase 2b study.
Larger Tumor Size Linked to Higher Mortality Risk in Brain Cancer
Investigators shared real-world data showing a clear and consistent association between increased tumor size and mortality for patients with brain cancer.
SENTI-202 Shows Positive Preliminary Data in Acute Myeloid Leukemia
A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid leukemia.
An AI-Driven Companion Diagnostic Receives FDA Designation in NSCLC
The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA in non–small cell lung cancer.
Investigating the Addition of Surgery to ICI Therapy in Kidney Cancer
Dr. Hyung L. Kim discusses how the addition of cytoreductive nephrectomy to ICI therapy may affect survival and quality of life those with kidney cancer.
TAR-200 Shows High Response Rates in Bladder Cancer Subset
TAR-200 showed high complete response rates in BCG-unresponsive, high-risk non-muscle invasive bladder cancer with CIS in the phase 2b SunRISe-1 study.
A Fellow Cancer Survivor Gives Me a Useful Message
A chance meeting with my childhood friend reminded me — and others — that living with cancer means taking things one day at a time.
FDA Approves Ready-to-Dilute Tepylute for Breast and Ovarian cancer
The FDA has granted approval to treatment with Tepylute, a ready-to-dilute version of thiotepa, at 100 mg for breast and ovarian cancers.
FDA Fast Tracks INX-315 for Tough-to-Treat Ovarian Cancer
INX-315, a CDK2 inhibitor, received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian cancer.
